{"nct_id":"NCT06008093","title":"A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-04-04","start_date_type":"ACTUAL","primary_completion_date":"2027-08-17","primary_completion_date_type":"ESTIMATED","completion_date":"2031-03-20","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}